"Except the mice with disabled CCR5 (-/- in the original abstract, which did not translate here; i.e. the knockout mice) showed increased mortality, so it really doesn't support leronlimab or other CCR5 targeted drug being effective in sepsis.

I guess I should have searched out the original abstract. Do you have a link for the original?



Read More: https://investorshangout.com/post/newpost/605...z81o0F1wQi